-
Enrollment Starting Soon in Phase 2b/3 Trial of Ibudilast for ALS
MediciNova has launched the Phase 2b/3 clinical trial that will explore the potential of ibudilast in patients with amyotrophic lateral sclerosis (ALS). Read more about it here.
Have you ever participated in a clinical trial? What was your experience like?
Sorry, there were no replies found.
Log in to reply.